Cite
HARVARD Citation
O'Kane, C. et al. (n.d.). S94 Tumour Necrosis Factor receptor 1 inhibition using a novel inhaled human antibody reduces inflammation in a human model of lung injury induced by inhaled lipopolysaccharide; a randomised placebo-controlled clinical trial. Thorax. pp. A50-A51. [Online].